tiprankstipranks
Advertisement

SMDX - ETF AI Analysis

Compare

Top Page

SMDX

Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX)

Rating:70Outperform
Price Target:
SMDX, the Intech S&P Small-Mid Cap Diversified Alpha ETF, has an overall rating that suggests it is a solid but not top-tier fund, supported by several strong individual holdings. Standout positions like East West Bancorp, Exelixis, and United Therapeutics contribute positively through strong financial performance, robust growth prospects, and generally supportive technical trends, while names like Pure Storage and Aecom introduce some drag due to bearish or mixed technical signals and valuation concerns. The main risk factor is that several holdings face issues such as high leverage, profitability or cash flow challenges, and valuation pressures, which could increase volatility even though the fund is diversified across many stocks.
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many different sectors, which can help reduce the impact if any one industry struggles.
Generally Strong Recent Performance
The fund has shown solid gains over the past month, quarter, and year-to-date, indicating positive recent momentum.
Moderate Expense Ratio
The fund’s fee is reasonable for an actively managed small- and mid-cap strategy, allowing investors to keep more of their returns compared with higher-cost funds.
Negative Factors
Single-Country Concentration
Almost all of the ETF’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Exposure to More Volatile Smaller Companies
Because the ETF focuses on small- and mid-cap stocks, its share price may move up and down more sharply than funds holding larger, more established companies.
Mixed Results Among Top Holdings
A few of the largest positions have shown weak or negative performance recently, which could drag on the fund if those stocks do not recover.

SMDX vs. SPDR S&P 500 ETF (SPY)

SMDX Summary

The Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX) invests in smaller and mid-sized U.S. companies from the S&P 1000, aiming to find stocks with strong growth potential outside the big, well-known large caps. It spreads money across many sectors, including industrials, financials, technology, and health care, with holdings like Jones Lang Lasalle and Tenet Healthcare. Someone might consider this ETF to diversify their portfolio and tap into the long-term growth potential of smaller companies. However, small- and mid-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The expense ratio for the Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized strategy to select stocks with growth potential.
What would affect this ETF?The SMDX ETF, which focuses on small- to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as smaller companies often have higher borrowing costs, or if economic uncertainty impacts consumer spending and industrial activity. Its focus on U.S. markets also makes it sensitive to domestic regulatory changes and geopolitical events.

SMDX Top 10 Holdings

SMDX is leaning into U.S. small- and mid-cap names, with a clear tilt toward industrials, financials, and health care rather than the usual Big Tech suspects. nVent Electric has been a standout, giving the fund a strong industrial spark, while Ormat Technologies and Lamar Advertising add steady tailwinds from energy and real estate. On the flip side, Jones Lang LaSalle and Tenet Healthcare have been losing steam lately, acting as mild brakes on performance. Overall, the ETF’s story is a domestically focused, sector-diversified hunt for under-the-radar growth.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
East West Bancorp1.25%$1.63M$17.99B42.49%
79
Outperform
Jones Lang Lasalle1.20%$1.57M$13.84B29.54%
79
Outperform
US Foods Holding1.05%$1.36M$20.58B23.27%
74
Outperform
Tenet Healthcare1.02%$1.33M$15.43B9.61%
74
Outperform
Lamar Advertising1.01%$1.32M$15.68B26.32%
72
Outperform
XPO0.96%$1.25M$25.92B78.87%
70
Outperform
Exelixis0.88%$1.14M$13.32B25.98%
78
Outperform
United Therapeutics0.86%$1.12M$23.33B91.11%
79
Outperform
Aecom Technology0.84%$1.10M$8.94B-36.65%
71
Outperform
Everpure0.80%$1.04M$24.83B39.89%
64
Neutral

SMDX Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
25.72
Positive
100DMA
24.93
Positive
200DMA
23.83
Positive
Market Momentum
MACD
0.26
Negative
RSI
59.39
Neutral
STOCH
75.47
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMDX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.11, equal to the 50-day MA of 25.72, and equal to the 200-day MA of 23.83, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 59.39 is Neutral, neither overbought nor oversold. The STOCH value of 75.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMDX.

SMDX Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$130.31M0.35%
70
Outperform
$778.25M0.75%
69
Neutral
$746.13M0.62%
64
Neutral
$484.13M0.75%
70
Outperform
$271.17M0.55%
68
Neutral
$177.06M1.10%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
26.51
6.30
31.17%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
SMIZ
Zacks Small/Mid Cap ETF
MGMT
Ballast Small/Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement